index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Biomarker Myopathy AAV Antibody responses Systems biology Lysosomal storage diseases Cancer CD8+T cells Case reports Interferon Antisynthétase Adult Machine learning Deep immune profiling COVID-19 Adjudication Idiopathic inflammatory myopathies Myositis Anti-drug antibodies Acute Kidney Injury/epidemiology/etiology Biopsy Inclusion body myositis Animals Acid-alpha-glucosidase Male Humans Aldostérone Anti-Mi2 AAV humoral immunity Antiphospholipid syndrome Aldosterone Antibodies Abnormal movement Autoimmune diseases Fabry disease CD8+ T-bet+ cells Analyses multidimensionnelles Anémie hémolytique Adverse drug reactions B cell homeostasis Amyotrophy Antisynthetase syndrome Myositis and muscle disease Biomarkers Anti-agalsidase antibodies AAV antibody Autoantibody Cytokines Aged Dependovirus/genetics/immunology Muscle Adolescence Anticorps anti-agalsidase Arthritis Auto-antibodies Adeno-associated vector Prognosis Anti-IgE IgG Middle Aged Dermatomyositis Inflammation Auto-immunité Antisynthetase IBM Anti-MDA5 autoantibodies Outcome measures Polymyositis Bioelectrical impedance analysis Biomarqueurs Immune checkpoint inhibitors Anticorps spécifique des myosites Active Mass cytometry B-lymphocyte Interstitial lung disease Adeno-associated virus vector Anti‐mitochondrial antibodies Agalsidase Multidisciplinarity Amyotrophic lateral sclerosis Adeno-associated virus Myocarditis Anti-interleukin-6 Autoantibodies Inborn errors of metabolism Assisted communication devices IMNM Inflammatory myopathy DM Female Autoimmunity Anti-synthetase syndrome AAV vectors Data integration Sphingosine-1-phosphate Skeletal muscle Auto‐antibodies AAV vector Immunotherapy Gene therapy